ARTICLE | Clinical News

Proellex: Phase II start

July 26, 2010 7:00 AM UTC

Repros plans to begin a Phase II trial in August or early September of low-dose Proellex after an investigational review board approved the study. The trial will evaluate 1, 3, 6, 9 and 12 mg doses of...